Who Owns INTS?

Intensity Therapeutics, Inc. — Institutional Ownership & 13F Holdings

$5.20

+0.04 (+0.87%)

Market Cap

$14.7M

Shares Outstanding

1,885,957

Institutional Holders

21

Total Inst. Value

$3.2M

% of Float Held

QoQ Holder Change

+5

Institutional data as of Q1 2025

New Positions

3

Closed Positions

3

Increased

8

Decreased

4

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1ARMISTICE CAPITAL, LLC$1.7M872,547
2VANGUARD GROUP INC$454K230,659
3BROWN ADVISORY INC$256K130,072
4GEODE CAPITAL MANAGEMENT, LLC$152K77,482
5Sigma Planning Corp$108K54,837
6Mesirow Financial Investment Management, Inc.$79K40,000
7BLAIR WILLIAM & CO/IL$74K37,805
8One Charles Private Wealth Services, LLC$63K31,800
9Rothschild Wealth LLCNew$54K27,304
10CITADEL ADVISORS LLC$51K25,801

Biggest Buyers & Sellers This Quarter

Related Stocks

Frequently Asked Questions

How many institutional investors hold INTS?

As of Q1 2025, 21 institutional investors report holding INTS (Intensity Therapeutics, Inc.) in their 13F filings.

Which hedge fund owns the most INTS?

The largest institutional holder of INTS is ARMISTICE CAPITAL, LLC with $1.7M in shares.

Are institutions buying or selling INTS?

This quarter, 3 institutions opened new positions in INTS and 3 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.